CM Hospitalar (Viveo, VVEO3) approved in a board of directors’ meeting held on Monday, October 19, 2026, bringing forward to October 26, 2026 the end of the subscription period for remaining shares and requests for additional remaining shares under the capital increase of up to R$ 869,761,072.80, through the issuance of up to 966,401,192 new common shares at a price of R$ 0.90 per share, with a minimum subscription of 474,444,722 shares, equivalent to R$ 427,000,249.80.
The remaining shares subscription period, which was previously scheduled to end on October 28, 2026, will now run from September 9 to October 26, 2026, with no further extension planned. During the preemptive rights period, which ended on August 31, 2026, 700,381,129 new shares were subscribed, for a total amount of R$ 630,343,016.10, corresponding to 72.47% of the maximum amount of the capital increase, leaving 266,020,063 unsubscribed shares for the remaining shares period.
According to the company, the previous extension of the remaining shares period until October 28, 2026 was linked to a conditional commitment to subscribe remaining shares undertaken by Banco BTG Pactual S.A., subject to the final and unappealable approval by the Administrative Council for Economic Defense (CADE) of the resulting equity interest. The transaction was approved without restrictions by CADE on September 23, 2026, with the decision becoming final on October 9, 2026, which led the board to bring forward the closing date in order to enable ratification of the capital increase and issuance of the subscribed shares.
Holders of remaining share subscription rights who wish to pay up shares through the capitalization of credits held against the company must transfer rights and credits to the book-entry environment by October 21, 2026. These holders, as well as those who wish to assign remaining rights to third parties, must observe the deadlines and procedures of B3 and Itaú Corretora de Valores S.A., as set out in previous notices to shareholders.
The company released an estimated timetable with the end of the remaining shares period on October 26, 2026, a notice on the fulfillment of requests for additional remaining shares on October 27, settlement of the remaining shares on October 29, and a board meeting on October 30, 2026 to deliberate on the ratification of the capital increase. The start dates for trading of the new shares on November 3, 2026 and for updating positions in the Central Depository on November 4, 2026 depend on the ratification of the capital increase and confirmation by B3 and Itaú Corretora. The other terms of the capital increase, including the remaining shares percentage of 54.04423738584% and the issue price of R$ 0.90 per share, were confirmed with no changes.
